Markets Edge — Capital flows, CMO moves, M&A

ISABELLA'S ISLAY M&A Intelligence Apr 22, 11:02 AM EDT

Gilead Sciences

Gilead completes Arcellx acquisition; tender offer extended pending final consent

Gilead Sciences received all required regulatory approvals for its acquisition of Arcellx and extended the tender offer deadline to accommodate final shareholder consent processes.

ReadingBig Pharma has confirmed cell therapy is now infrastructure, not frontier. Smaller biotech founders still pricing for autonomy need to recalibrate downward by 30-50%.

WatchNext Gilead integration announcement will telegraph which Arcellx programs get accelerated and which get shelved. Within 45 days.

Read full analysis → Original ↗

m&abiotechcell therapypharma

HENRI IV Capital Markets Apr 22, 11:02 AM EDT

Scholastic Corporation

PR Newswire ↗

Scholastic launches $200M share repurchase; capital deployment signal

Scholastic Corporation announced a cash tender offer to purchase up to $200 million of its common stock, representing a significant capital return to shareholders.

ReadingScholastic's board believes the stock is undervalued relative to asset value. Insiders walking past external growth targets and buying their own security.

WatchWatch Q2 earnings guidance. If buyback accelerates alongside margin expansion, the stock reprices higher. If cash flow tightens, the offer gets modified or suspended.

Read full analysis → Original ↗

capital marketsbuybackvaluationcash deployment

MACALLAN 1926 M&A Intelligence Apr 22, 11:02 AM EDT

Assertio Therapeutics

TradingView ↗

Garda acquires Assertio in $125.1M cash tender offer at $18 per share

Garda has announced a cash tender offer to acquire all shares of Assertio Therapeutics at $18.00 per share, representing total consideration of $125.1 million.

ReadingSPAC-era valuations are now acquisition prices. Founders who priced at $5B in 2021 are now accepting $125M. The reset happened quietly.

WatchWatch for Garda's next two targets. Roll-ups never stop at one. The playbook requires 3-5 bolt-on acquisitions to justify the parent thesis.

Read full analysis → Original ↗

m&aspecialty pharmatender offerconsolidation

LOUIS XIII M&A Intelligence Apr 22, 11:02 AM EDT

Selectis Health

McKnight's Senior Living ↗

Black Pearl files tender offer for all shares of Selectis Health

Black Pearl announced a tender offer to acquire all outstanding shares of Selectis Health, marking entry into the senior care operator consolidation wave.

ReadingSelectis shareholders are getting acquired. The operator window for independence closed 18 months ago. Any remaining standalone senior care players have six quarters to find a buyer before valuation deteriorates further.

WatchWatch acquisition price and earnout structure. If earnout exceeds 30% of total consideration, Black Pearl is hedging on integration risk. That signals execution concerns post-close.

Read full analysis → Original ↗

m&asenior careconsolidationhealthcare services

PAPPY 23 Procurement Intelligence Apr 22, 11:02 AM EDT

Micron Technology

Governor Kathy Hochul (.gov) ↗

New York groundbreaking: Micron semiconductor fab marks state subsidy deployment

Governor Hochul celebrated the groundbreaking of Micron Technology's semiconductor manufacturing facility in Central New York, marking the start of a major capital project with substantial state incentives.

ReadingSemiconductor supply security is now geopolitical infrastructure. Companies bidding for state incentives no longer compete on cost alone. Fabs are quasi-public utilities.

WatchMonitor Micron's capex guidance this quarter. If they announce additional U.S. facility plans, it signals confidence in sustained government support. If guidance stays flat, it signals the New York deal was one-off.

Read full analysis → Original ↗

semiconductorcapexgovernment subsidymanufacturing

JOHNNIE BLUE Global Business News Apr 22, 11:02 AM EDT

Family Offices (Sector-Wide)

Goldman Sachs ↗

40% of family offices raising public/private equity allocations; sector drift confirmed

Nearly 40% of family offices plan to raise allocations to both public and private equity, signaling a strategic reallocation away from bonds and alternative fixed-income strategies.

ReadingFamily offices are frontrunning anticipated interest rate environment. If rates stay elevated, these allocations reverse within 12 months and damage credibility. If rates fall 150bps, these allocations lock in early advantage.

WatchTrack Q2 family office capital deployment metrics. If private equity deal flow accelerates alongside rising allocations, it confirms the thesis. If capital sits undeployed, it signals hesitation post-allocation announcement.

Read full analysis → Original ↗

family officesallocationcapital deploymentequity markets

WELL POUR Capital Markets Apr 22, 11:02 AM EDT

Urgent.ly (ULY)

Stock Titan ↗

Urgent.ly shareholders approve $5.50-per-share tender offer; proxy filing updated

Urgent.ly updated its proxy solicitation filing as the $5.50-per-share tender offer proceeds toward completion, indicating continued shareholder support for the transaction.

Reading$5.50 per share is the final offer. No counter-bid emerged. Shareholders who expected higher will learn patience was not rewarded.

WatchClosing timeline. If deal closes within 30 days, buyer had no contingencies. If extensions extend beyond 60 days, there are financing or regulatory complications.

Read full analysis → Original ↗

m&atender offershareholder votedeal closing